Cargando…

Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine

More effective rotavirus vaccines are essential for preventing extensive diarrheal morbidity and mortality in children under five years of age in low-resource regions. Nonreplicating rotavirus vaccines (NRRV) administered parenterally provide an alternate vaccination method to the current licensed o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lakatos, Kyle, McAdams, David, White, Jessica A., Chen, Dexiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482676/ https://www.ncbi.nlm.nih.gov/pubmed/31995444 http://dx.doi.org/10.1080/21645515.2019.1710412

Ejemplares similares

Quantification of trivalent non-replicating rotavirus vaccine antigens in the presence of aluminum adjuvant
por: McAdams, David, et al.
Publicado: (2021)

A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses
por: Xia, Ming, et al.
Publicado: (2021)

Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial
por: Groome, Michelle J, et al.
Publicado: (2020)

Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation
por: Flood, Alexander, et al.
Publicado: (2016)

Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens
por: Agarwal, Sanjeev, et al.
Publicado: (2019)

Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine
por: Lappalainen, Suvi, et al.
Publicado: (2015)

The Functional Characterization of Bat and Human P[3] Rotavirus VP8*s
por: Li, Dandi, et al.
Publicado: (2021)

Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus
por: Dalvie, Neil C., et al.
Publicado: (2021)

The rotavirus VP5*/VP8* conformational transition permeabilizes membranes to Ca(2+)
por: De Sautu, Marilina, et al.
Publicado: (2023)

Glycan binding patterns of human rotavirus P[10] VP8* protein
por: Pang, Li-li, et al.
Publicado: (2018)

Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial
por: Groome, Michelle J, et al.
Publicado: (2017)

Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens
por: Agarwal, Sanjeev, et al.
Publicado: (2020)

Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine
por: Maina, Meshach Maunta, et al.
Publicado: (2022)

Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial
por: Fellows, Tamika, et al.
Publicado: (2023)

Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only
por: Heinimäki, Suvi, et al.
Publicado: (2020)

Plasma VP8∗-Binding Antibodies in Rotavirus Infection and Oral Vaccination in Young Bangladeshi Children
por: Lee, Benjamin, et al.
Publicado: (2021)

Structural basis of glycan specificity of P[19] VP8*: Implications for rotavirus zoonosis and evolution
por: Liu, Yang, et al.
Publicado: (2017)

Trivalent Combination Vaccine Induces Broad Heterologous Immune Responses to Norovirus and Rotavirus in Mice
por: Tamminen, Kirsi, et al.
Publicado: (2013)

Sero-epidemiological study of the rotavirus VP8* protein from different P genotypes in Valencia, Spain
por: Vila-Vicent, Susana, et al.
Publicado: (2020)

A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response
por: Xia, Ming, et al.
Publicado: (2022)

Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in Nicotiana benthamiana
por: Malm, Maria, et al.
Publicado: (2019)

Design and Construction of Chimeric VP8-S2 Antigen for Bovine Rotavirus and Bovine Coronavirus
por: Nasiri, Khadijeh, et al.
Publicado: (2016)

Parenterally Administered P24-VP8* Nanoparticle Vaccine Conferred Strong Protection against Rotavirus Diarrhea and Virus Shedding in Gnotobiotic Pigs
por: Ramesh, Ashwin, et al.
Publicado: (2019)

Vaccinomics Approach for Multi-Epitope Vaccine Design against Group A Rotavirus Using VP4 and VP7 Proteins
por: Usman, Muhammad, et al.
Publicado: (2023)

Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection
por: Kumar, Sudeep, et al.
Publicado: (2020)

Molecular basis of P[II] major human rotavirus VP8* domain recognition of histo-blood group antigens
por: Xu, Shenyuan, et al.
Publicado: (2020)

Combined Live Oral Priming and Intramuscular Boosting Regimen with Rotarix(®) and a Nanoparticle-Based Trivalent Rotavirus Vaccine Evaluated in Gnotobiotic Pig Models of G4P[6] and G1P[8] Human Rotavirus Infection
por: Hensley, Casey, et al.
Publicado: (2023)

An in-vitro transcription assay for development of Rotavirus VP7
por: Jalilian, Shahram, et al.
Publicado: (2017)

Classification of group A rotavirus VP7 and VP4 genotypes using random forest
por: Tran, Hoc, et al.
Publicado: (2023)

Codon usage of host-specific P genotypes (VP4) in group A rotavirus
por: Wu, Han, et al.
Publicado: (2022)

Detection of mutations in the VP7 gene of vaccine-derived strains shed by monovalent rotavirus vaccine recipients
por: Kaneko, Mei, et al.
Publicado: (2019)

A New Gnotobiotic Pig Model of P[6] Human Rotavirus Infection and Disease for Preclinical Evaluation of Rotavirus Vaccines
por: Nyblade, Charlotte, et al.
Publicado: (2022)

Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
por: Luo, Guoxing, et al.
Publicado: (2022)

Genetic analysis of Ghanaian G1P[8] and G9P[8] rotavirus A strains reveals the impact of P[8] VP4 gene polymorphism on P-genotyping
por: Damanka, Susan Afua, et al.
Publicado: (2019)

Concordance of in vitro and in vivo measures of non-replicating rotavirus vaccine potency
por: McAdams, David, et al.
Publicado: (2022)

Intracellular neutralisation of rotavirus by VP6-specific IgG
por: Caddy, Sarah L., et al.
Publicado: (2020)

Probiotic as Adjuvant Significantly Improves Protection of the Lanzhou Trivalent Rotavirus Vaccine against Heterologous Challenge in a Gnotobiotic Pig Model of Human Rotavirus Infection and Disease
por: Parreno, Viviana, et al.
Publicado: (2022)

Rotavirus spike protein ΔVP8* as a novel carrier protein for conjugate vaccine platform with demonstrated antigenic potential for use as bivalent vaccine
por: Park, Wook-Jin, et al.
Publicado: (2021)

Strain-Specific Interactions between the Viral Capsid Proteins VP4, VP7 and VP6 Influence Rescue of Rotavirus Reassortants by Reverse Genetics
por: Valusenko-Mehrkens, Roman, et al.
Publicado: (2023)

In Silico Study of Rotavirus VP7 Surface Accessible Conserved Regions for Antiviral Drug/Vaccine Design
por: Ghosh, Ambarnil, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bc3i3ft20pmbv4p1k4urp7ofru